Heterogeneous Treatment Effect Estimation using machine learning for
  Healthcare application: tutorial and benchmark
  Developing new drugs for target diseases is a time-consuming and expensive
task, drug repurposing has become a popular topic in the drug development
field. As much health claim data become available, many studies have been
conducted on the data. The real-world data is noisy, sparse, and has many
confounding factors. In addition, many studies have shown that drugs effects
are heterogeneous among the population. Lots of advanced machine learning
models about estimating heterogeneous treatment effects (HTE) have emerged in
recent years, and have been applied to in econometrics and machine learning
communities. These studies acknowledge medicine and drug development as the
main application area, but there has been limited translational research from
the HTE methodology to drug development. We aim to introduce the HTE
methodology to the healthcare area and provide feasibility consideration when
translating the methodology with benchmark experiments on healthcare
administrative claim data. Also, we want to use benchmark experiments to show
how to interpret and evaluate the model when it is applied to healthcare
research. By introducing the recent HTE techniques to a broad readership in
biomedical informatics communities, we expect to promote the wide adoption of
causal inference using machine learning. We also expect to provide the
feasibility of HTE for personalized drug effectiveness.
